Navigation Links
More cutting-edge cancer research supported by industry
Date:5/17/2012

CHICAGO, IL (May 16, 2012)Nearly half of the research presented at ASCO's annual meeting last year came from researchers with ties to companies, and the amount appears to be increasing every year, according to new findings from Fox Chase Cancer Center. The new findings will be presented this year at the 2012 American Society of Clinical Oncology Annual Meeting on Monday, June 4.

"The results suggest that there may be an increasing dependence on industry to support cancer research," says study author Angela R. Bradbury, M.D., assistant professor in the Department of Clinical Genetics at Fox Chase. "This doesn't mean the research is flawed or biased in any way," she cautions, "but it does mean that the professional and research community has to investigate the impact of these relationships and find ways to manage any potential conflicts of interest."

Bradbury and her colleagues reviewed research submitted to the 2011 American Society of Clinical Oncology Annual Meeting, which requires all authors who want to present their findings to state if they have any relationships with industry. This includes being employed by a company, as well as owning stock, serving as a consultant or expert witness, and receiving honoraria for giving talks or participating in research projects.

They found that 48% of research accepted for presentation at the meeting in 2011 came from a group where at least one author had a relationship to industryup from 39% of research presented in 2006. These ties to industry appeared to increase every year.

Interestingly, in a second related abstract by the same authors, Beverly Moy, M.D., M.P.H., clinical director of the Breast Oncology Program and a medical oncologist at the Massachusetts General Hospital, reported that high profile researchselected to be presented more prominently at the meetingwas more likely to come from scientists with relationships to industry. Studies from authors with ties to industry
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Conference: Improving K-12 education with cutting-edge cognitive neuroscience research
2. AGA presents cutting-edge research during DDW
3. Cutting-edge salivary diagnostics research presented at AADR 3rd Fall Focused Symposium
4. From cholera to blindness, experts present cutting-edge research at international meeting
5. New book offers cutting-edge perspective on causes of schizophrenia; related disorders
6. AGA presents cutting-edge research during DDW
7. Singapore Performs Cutting-edge Eye Surgeries
8. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
9. Researchers undertake radical new cancer survivorship study
10. Hybrid vaccine demonstrates potential to prevent breast cancer recurrence
11. Advanced Prostate Cancer Drug May Help at Earlier Stage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world leader in ... its award-winning print and artwork inspection solutions, ScanProof and ArtProof at Packaging ... the Olympia London, booth #F33 , Be the first to get a sneak peek ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters ... pleased to announce the additional of Carol Wysham, MD, to their esteemed Board ... Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda ...
(Date:9/3/2015)... ... ... ProScrub is a set of automated tools that allow Final Cut Pro ... without the use of keyframes. Utilize ProScrub's powerful sliders to determine the number ... to energetic video productions. ProScrub is a Final Cut Pro X ...
(Date:9/3/2015)... Jersey City, NJ (PRWEB) , ... September 03, 2015 , ... ... devices, announced today that AvePoint Perimeter Service Pack (SP) 4 – AvePoint’s ... – has been named a “KMWorld 2015 Trend-Setting Product”. This is the ...
(Date:9/3/2015)... ... 03, 2015 , ... Representatives with State Farm Agent EJ ... Mississippi Gulf Babypalooza on September 19, 2015. , “We will be providing information ... beyond. We will be discussing setting up college funds, offering information specific to ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2
... mass, but long-term effects on vitality unclear, scientists say ... experimental drug can restore the amounts of muscle-linked growth ... shows. , Those on the therapy also gained muscle ... no clear indication that this led to significant improvements ...
... percent versus third quarter last year ... 4:30 p.m. Eastern Time Today, IRVINE, Calif., Nov. 6 ... intravascular temperature,management (IVTM(TM)) therapies for critically ill patients, today reported,on ... and,nine months ended September 30, 2008., Revenue for the ...
... Company Delivers First Month of Positive Gross Profits ... Corporation,(Nasdaq: PODD ), the leader in patch pump ... results for the three,and nine months ended September 30, ... $10.1 million compared to,$3.8 million in the third quarter ...
... November 06, 2008 Down syndrome, the most ... 1-in-700 births in the United States. Additionally, nearly 80 ... birth. , The Centers for Disease Control (CDC), in ... meeting of experts to review the current knowledge of ...
... STEWARTVILLE, Minn., Nov. 6 Rochester Medical,Corporation (Nasdaq: ... and year ended September 30, 2008., The Company ... to $8,437,000 for the fourth quarter of last year. ... $.03 per diluted share,compared to $733,000 or $.06 per ...
... ... Expectations, DENVER, Nov. 6 Air Methods ... 2008.,Revenue increased 32% to $133.8 million from $101.5 million in the year-ago,quarter. ... million in the prior-year nine-month period., For the quarter, net income ...
Cached Medicine News:Health News:Drug Boosts Natural Growth Hormone in Seniors 2Health News:Drug Boosts Natural Growth Hormone in Seniors 3Health News:Drug Boosts Natural Growth Hormone in Seniors 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 2Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 3Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 5Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 6Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 7Health News:Insulet Reports Third Quarter 2008 Results 2Health News:Insulet Reports Third Quarter 2008 Results 3Health News:Insulet Reports Third Quarter 2008 Results 4Health News:Insulet Reports Third Quarter 2008 Results 5Health News:Insulet Reports Third Quarter 2008 Results 6Health News:Insulet Reports Third Quarter 2008 Results 7Health News:Insulet Reports Third Quarter 2008 Results 8Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 2Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 3Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 4Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 5Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 6Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 7Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 8Health News:Air Methods Reports 3Q2008 Results and 4Q2008 Update 2Health News:Air Methods Reports 3Q2008 Results and 4Q2008 Update 3Health News:Air Methods Reports 3Q2008 Results and 4Q2008 Update 4Health News:Air Methods Reports 3Q2008 Results and 4Q2008 Update 5Health News:Air Methods Reports 3Q2008 Results and 4Q2008 Update 6Health News:Air Methods Reports 3Q2008 Results and 4Q2008 Update 7
(Date:9/2/2015)... THOUSAND OAKS, Calif. , Sept. 2, 2015 ... announced the submission of a Marketing Authorization Application ... the centralized procedure for etelcalcetide (formerly AMG 416) ... adult patients with chronic kidney disease (CKD) on ... first calcimimetic agent that can be administered intravenously. ...
(Date:9/2/2015)... Miss. , Sept. 2, 2015   Gulf Coast Tattoo ... removal services with the cutting-edge Astanza Duality laser in ... unwanted ink erase their tattoo regret and take back control of ... but extends its services to Biloxi ... region. "With tattoo regret being as prevalent as it ...
(Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/6mlrvg/an_introduction ... "An Introduction to Medical Device Software: Regulations and ... conference to their offering. This ... regulations and requirements that apply to Medical Device ... real life examples and state-of- the-art practices identified ...
Breaking Medicine Technology:Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
... and CAMPBELL, Calif. , May ... sophisticated risk characterization and personalized therapy guidelines for ... of advanced tests, offering an accompanying nutrition program, ... Director stated:  "With appropriate risk characterization and treatment, ...
... May 25 The U.S. Food and Drug Administration approved Lumizyme (alglucosidase ... a rare genetic disorder. , , ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , , , ... an estimated 1 in every 40,000 to 300,000 births. Its primary symptom is ...
Cached Medicine Technology:Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program. 2FDA Approves New Treatment for Late-Onset Pompe Disease 2FDA Approves New Treatment for Late-Onset Pompe Disease 3
... flexible lighting products. The first is available ... sizes 5", 10", and 15" (refers to ... These lights are for use in procedures ... second group of flexible lights is our ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
... standby switch maintains power to the instrument without generating ... of 50 Hz separated by .75 s; repeats every ... Hz (2 pulses/s) , Tetanus: 50 Hz (50 ... pulses/2 s; repeats every 10 s , Output Current: ...
Medicine Products: